What are the recommended dosing, titration, monitoring, and contraindications for combining Lexapro (escitalopram) with Strattera (atomoxetine)?

Combining Lexapro (Escitalopram) and Strattera (Atomoxetine)

Combining Lexapro and Strattera requires careful monitoring for serotonin syndrome, as both medications have serotonergic activity, though the risk is lower than with other combinations since atomoxetine primarily affects norepinephrine. 1

Key Safety Considerations

Serotonin Syndrome Risk

• Monitor closely for serotonin syndrome symptoms within the first 24-48 hours after initiating combination therapy or any dose changes 1
• Symptoms to watch for include: mental status changes (confusion, agitation, anxiety), neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity), and autonomic hyperactivity (hypertension, tachycardia, diaphoresis, vomiting, diarrhea) 1
• While atomoxetine is primarily a norepinephrine reuptake inhibitor, it does have some serotonergic activity (approximately 16-40% SERT inhibition at therapeutic doses), making this combination safer than combining two SSRIs but still requiring vigilance 2

Drug Interaction Considerations

• Escitalopram has minimal effect on CYP450 enzymes compared to other SSRIs, reducing the risk of pharmacokinetic interactions with atomoxetine 1
• Atomoxetine is metabolized primarily through CYP2D6, and escitalopram does not significantly inhibit this pathway 3, 4
• This combination is pharmacologically safer than using atomoxetine with paroxetine or fluoxetine, which are potent CYP2D6 inhibitors 1, 4

Dosing and Titration Protocol

Escitalopram (Lexapro) Dosing

• Start at 10 mg daily 5, 6
• Maximum dose: 40 mg daily (note: doses exceeding 40 mg/day are associated with QT prolongation risk) 1
• Titrate in 1-2 week intervals for shorter half-life SSRIs like escitalopram 1

Atomoxetine (Strattera) Dosing

For patients weighing ≤70 kg:

• Initial: 0.5 mg/kg/day 4
• Target: 1.2 mg/kg/day 4
• Maximum: 1.4 mg/kg/day or 100 mg/day, whichever is lower 4

For patients >70 kg and adults:

• Initial: 40 mg/day 4
• Target: 80 mg/day 4
• Maximum: 100 mg/day 4

Combination Initiation Strategy

When combining these medications, use the following approach:

1. If starting both simultaneously: Begin escitalopram at 10 mg daily and atomoxetine at the lower initial dose (0.5 mg/kg or 40 mg), monitoring closely for 48 hours before any dose adjustments 1, 4

2. If adding atomoxetine to established escitalopram: Start atomoxetine at the standard initial dose and increase slowly every 5-7 days, monitoring for serotonergic symptoms 1, 4

3. If adding escitalopram to established atomoxetine: Start escitalopram at 5-10 mg daily (consider lower dose in cautious approach) and monitor for 24-48 hours before increasing 1

Monitoring Requirements

Cardiovascular Monitoring

• Baseline and periodic blood pressure and heart rate monitoring are essential, as both medications can affect cardiovascular parameters 7, 4
• Atomoxetine can increase heart rate and blood pressure; escitalopram may cause QT prolongation at higher doses 1, 4
• Obtain baseline ECG if patient is >40 years old or has cardiac risk factors 7, 4

Psychiatric Monitoring

• Monitor for suicidal ideation, especially in children and adolescents during the first few months of atomoxetine treatment or at times of dose changes 3, 4
• Assess for emergent psychotic or manic symptoms, particularly in patients with undiagnosed bipolar disorder 4
• Monitor for aggressive behavior or hostility 3, 4

Physical Monitoring

• Growth parameters (height and weight) should be monitored in pediatric patients on atomoxetine 3, 4
• Monitor for urinary hesitancy or retention with atomoxetine 4
• Assess liver function if signs of hepatic injury develop (jaundice, dark urine, right upper quadrant tenderness) 4

Contraindications

Absolute Contraindications for This Combination

• Concurrent use with MAOIs or within 14 days of MAOI discontinuation 1, 4
• Narrow-angle glaucoma (atomoxetine contraindication) 4
• Pheochromocytoma or history thereof (atomoxetine contraindication) 4
• Severe cardiovascular disorders that might deteriorate with increases in heart rate and blood pressure 4
• Known hypersensitivity to either medication 4

Relative Contraindications and Cautions

• Long QT syndrome or concomitant use of other QT-prolonging medications (escitalopram concern) 1
• Uncontrolled hypertension or tachycardia 4
• Structural cardiac abnormalities, cardiomyopathy, or serious heart rhythm abnormalities 4
• History of seizure disorder (use atomoxetine with caution) 4

Common Pitfalls to Avoid

1. Failing to educate patients about serotonin syndrome symptoms before initiating combination therapy 1

2. Rapid titration without adequate monitoring periods between dose increases 1, 4

3. Overlooking cardiovascular screening in patients with risk factors before starting atomoxetine 4

4. Not adjusting atomoxetine dose in patients taking strong CYP2D6 inhibitors (though escitalopram is not one) or in known CYP2D6 poor metabolizers 3, 4

5. Inadequate monitoring for suicidal ideation in younger patients, particularly during the first months of treatment 3, 4

6. Abrupt discontinuation of escitalopram, which can cause discontinuation syndrome (though less severe than with paroxetine) 1

Clinical Advantages of This Combination

• Escitalopram has the lowest propensity for drug-drug interactions among SSRIs, making it a safer choice when combining with atomoxetine 1
• This combination addresses both serotonergic and noradrenergic systems, which may be beneficial for patients with comorbid depression and ADHD 8, 2
• Atomoxetine can be dosed once or twice daily, providing flexibility 4, 9
• Neither medication is a controlled substance, simplifying prescription management 9, 10